Julie Nangia Explains Scalp Cooling Devices for Chemotherapy Induced Hair Loss


Julie Nangia explains the process for the Orbis Paxman Hair Loss Prevention System.

Julie Nangia, MD, Baylor College of Medicine, explains the process for scalp cooling devices, in particular the Orbis Paxman Hair Loss Prevention System.

The device is used to prevent chemotherapy-induced hair loss. It is worn by the patient before, for the duration of, and after chemotherapy. The device is fitted and sized to the patient and starts with a cold sensation that the patient gradually acclimates to. In recent trial that Nangia presented at the 2016 Annual Meeting of the San Antonio Breast Cancer Symposium, many of the patients reported on a comfort scale that the device was “reasonably” comfortable, according to Nangia. However, patients who have a history of migraines and headaches will not tolerate the device well.

Related Videos
Patrick Buxton, RN, BSN
Cheryl VerStrate on the Pitfalls of Direct-to-Consumer Genetic Tests
Elizabeth Aronson
MPN-Associated Anemia: What Nurses Should Look Out For
Cancer-Related Cognitive Impairment
Charina Toste
Lindsey Lyle
Related Content
© 2023 MJH Life Sciences

All rights reserved.